DPP4 and type 2 diabetes mellitus: The objectives of this study were to: 1) compare the characteristics of patients with T2DM who newly initiate saxagliptin to those who newly initiate OADs in classes other than DPP-4 inhibitors, and 2) identify determinants of saxagliptin use during the first years of its availability in the UK and US.